홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
EWTX
#1558
Edgewise Therapeutics, Inc. Common Stock
33.160
0
USD
-2.01%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-2.01%
월간 변동
+11.39%
6달 변화
+117.73%
년간 변동율
+117.73%
이전 종가
33.840
0
Open
33.160
0
Bid
Ask
Low
33.160
0
High
33.160
0
양
79
마켓
주식
헬스케어
EWTX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
49.51 M
63.26 M
93.11 M
95.21 M
107.27 M
—
Valuation ratios
Enterprise value
740.98 M
534.08 M
938.12 M
2.5 B
2.6 B
7.87 B
Price to earnings ratio
-13.4
-6.98
-7.01
-18.41
-15.22
-48.14
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-17.11
-8.95
-7.62
-22.63
-17.76
-57.56
Price to book ratio
2.09
1.36
2.2
5.37
4.89
7.42
EBITDA 비율에 대한 기업 가치
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.15
-0.18
-0.29
-0.27
-0.3
-0.31
Return on equity %
-0.16
-0.2
-0.31
-0.29
-0.32
-0.33
Return on invested capital %
-65.99
-96.33
-158.55
-187.92
-168.3
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
26.97
21.53
19.5
19.93
19.85
96.22
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.89
-0.98
-1.44
-1.18
-1.4
-1.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.41
0.41
1.35
0.45
0.59
1.97
Net current asset value per share
7.56
6.66
5.13
5.15
5.28
21.13
Tangible book value per share
7.31
6.47
5
4.97
5.07
20.5
Working capital per share
7.28
6.35
4.87
4.89
5.01
20.23
Book value per share
7.31
6.47
5
4.97
5.07
20.5
뉴스
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
JPMorgan raises Edgewise Therapeutics price target on pipeline outlook
레이먼드 제임스, Edgewise Therapeutics에 ’Strong Buy’ 의견 유지
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock after trial data
엣지와이즈 테라퓨틱스, Truist, 투자의견 재확인
Truist reiterates Edgewise Therapeutics stock rating on trial data
엣지와이즈, 베커병 임상서 기능적 안정성 보고
Edgewise reports functional stability in Becker dystrophy trial
에버코어 ISI, HCM 데이터에 힘입어 Edgewise Therapeutics 목표 주가 상향
Evercore ISI raises Edgewise Therapeutics price target on HCM data
레이먼드 제임스, Edgewise Therapeutics에 ’Strong Buy’ 투자의견 유지
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock